Summary:
- The article examines the intersection of scientific research, regulatory frameworks, and consumer demand regarding peptides within the Brazilian market.
- It highlights the challenges of balancing the therapeutic potential of peptide-based treatments with the necessity of rigorous quality control and safety oversight by health authorities.
- The text emphasizes the growing interest in biotechnology and synthetic biology, underscoring the need for scientific literacy to distinguish between evidence-based medical applications and unregulated market trends.